Benefits and Side Effects of Methylene Blue – A Comprehensive Guide (2024 update, reprinting the Gonzalez-Lima interview) (2024)

Other · Mercola J (Mercola.com) · October 28, 2024

Mercola's 2024 rewritten guide states that serotonin syndrome "typically only occurs at high doses" and is "rarely, if ever" seen at the 3 to 5 mg doses he recommends, while also advising strong caution for anyone taking an SSRI; it introduces the earlier Gonzalez-Lima interview as a link to a video and transcript rather than reprinting it, and carries a G6PD warning stating methylene blue is contraindicated in that disorder.

This typically only occurs at high doses that are used to treat life threatening situations and is likely rarely, if ever, occur at lower doses that I recommend of 3 to 5 mg.

Mercola's 2024 rewritten guide states that serotonin syndrome "typically only occurs at high doses" and is "rarely, if ever" seen at the 3 to 5 mg doses he recommends, while also advising strong caution for anyone taking an SSRI; it introduces the earlier Gonzalez-Lima interview as a link to a video and transcript rather than reprinting it, and carries a G6PD warning stating methylene blue is contraindicated in that disorder. C2 and C10. Attributed to Mercola.com as published; not characterised as true or false. Note the internal tension on the same page: it advises "strong caution for anyone ever to take an SSRI drug" and simultaneously minimises risk at 3-5 mg. The "3 to 5 mg" figure is Mercola's own stated dose, recorded as published, not a dose recommendation by this record. The 2024 page no longer contains the "never been more than five cases" passage (checked: string absent), so the Gonzalez-Lima argument is sourced to the 2022 page. Also filed as MTO-63 (claims C10, C2). Study type: other.